Journals / JAREM / 2012 / Cilt: 2 - Sayı: 3

Antibiotic susceptibility of escherichia coli strains ısolated in community acquired urinary tract ınfections

Toplum kaynaklı üriner sistem enfeksiyonu etkeni olarak saptanan escherichia coli izolatlarının antibiyotik duyarlılıkları

Journal
JAREM
Pages
101–103
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Empirical therapy should be based on local antimicrobial resistance monitoring in order to optimize the use of these drugs.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to obtain data on susceptibility patterns of Escherichia coli strains responsible for community acquired urinary tract infections in a private hospital in Istanbul, Turkey.
📊
Key Findings & Data:Methods: Between the dates of 1 January 2008 and 31 December 2008 patients admitted to the urology outpatient department with suspected uri- nary tract infection and urine samples of patients with reproductive culture results were evaluated retrospectively.
💡
Conclusion & Impact:Conclusion: Empirical therapy should be based on local antimicrobial resistance monitoring in order to optimize the use of these drugs.
🔬Design:Research Article
📍Scope:2008 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: The aim of this study was to obtain data on susceptibility patterns of Escherichia coli strains responsible for community acquired urinary tract infections in a private hospital in Istanbul, Turkey. Methods: Between the dates of 1 January 2008 and 31 December 2008 patients admitted to the urology outpatient department with suspected uri- nary tract infection and urine samples of patients with reproductive culture results were evaluated retrospectively. Results: A total of 191 E. coli strains isolated from urine cultures which were processed between January 2008 and December 2008 in the clinical labo- ratory, were included in the study. Identification of bacteria and antibiotic susceptibility tests were performed by disk diffusion and automated system. Of E. coli strains, 14.6% (n=28) were found positive for ESBL. The resistance rates of E. coli strains were found as follows; 12.4% for nitrofurantoin, 40% for trimethoprim/sulfamethoxazole (TMP-SMX), 19.8% for ciprofloxacin and 19.2% for ceftriaxon. Conclusion: Empirical therapy should be based on local antimicrobial resistance monitoring in order to optimize the use of these drugs.

Özet

Amaç: Bu çalışmada, İstanbul’da bir özel hastanede toplum kökenli üriner sistem enfeksiyonlarından izole edilen Escherichia coli suşlarında antimik- robiyal duyarlılıklarının belirlenmesi amaçlanmıştır. Yöntemler: Üroloji polikliniğine 1 Ocak 2008-31 Aralık 2008 tarihleri arasında ayaktan üriner sistem enfeksiyonu şüphesi ile başvuran ve idrar örnekle- rinde üreme saptanan hastaların kültür sonuçları retrospektif olarak değerlendirildi. Bulgular: İzole edilen 191 E. coli suşunda disk difüzyon ve/veya otomatize sistem testleri ile trimetoprim-sulfametoksazol (TMP-SMX) (%40), siprof- loksasin (%19.8), seftriakson (%19.2) ve nitrofurantoin (%12.4), karşı direnç oranları saptandı. İzole edilen 191 E. coli’den 28’inde (%14.6) GSBL pozitif bulundu. Sonuç: Ampirik tedavi seçiminde, bölgesel antimikrobiyal direnç oranlarının bilinmesi, antibiyotiklerin etkin kullanılmasına katkıda bulunacaktır.

🔖

Cite This Article

GÖZÜKÜÇÜK, R., ÇAKIROĞLU, B., NAS, Y. (2012). Antibiotic susceptibility of escherichia coli strains ısolated in community acquired urinary tract ınfections. JAREM, Cilt: 2 - Sayı: 3, 101–103. https://ajindex.com/articles/215517

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (2)

  1. Topçu AW, Söyletir G, Doğanay M. Enfeksiyon Hastalıkları ve Mikro- biyolojisi 3.Baskı, Nobel Tıp Kitabevleri 2008. Cilt 1, p.1487-8. 2.Sobel JD, Kaye D. Urinary tract infections. “Mandell GL, Bennett JE, Dolin R (eds). Principles and Practice of Infectious Disease, 5th ed” p.773-800,
  2. Churcill Livingstone, Philadelphia (2000). 3.Öztürk CE, Kaya AD, Göçmen Ş, Arslan E. Toplum kaynaklı idrar yolu infeksiyonu etkeni olan Escherichia coli izolatlarının fosfomisin ile idrar yolu infeksiyonlarında sık kullanılan antibiyotiklere duyarlılıkları. ANKEM Derg 2008; 22: 81-4. 4.Güdücüoğlu H, Baykal S, İzci H, Berktaş M. Antimicrobial resistance of Escherichia coli and Klebsiella pneumonia strains that produce extended spectrum beta-lactamase. Joint Dis Rel Surg 2007; 21: 155-60. 5.Dromigny JA, Ndoye B, Macondo EA, Nabeth P, Siby T, Perrier-Gros- Claude JD. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Dakar, Senegal: a multicenter study. Diagn Microbiol Infect Dis 2003; 47: 595-600. [CrossRef] 6. Rock W, Colodner R, Chazan B, Elias M, Raz P. Ten years surveillance of antimicrobial susceptibility of communityacquired Escherichia coli and other uropathogens in Northern Israel (1995-2005). Isr Med As- soc J 2007; 9: 803-5. 7. Storby KA, Österlund A, Kahlmeter G. Antimicrobial resistance in Escherichia coli in urine samples from children and adults: a 12 year analysis. Acta Paediatr 2004; 93: 487-91. [CrossRef] 8. Karaca Y, Coplu N, Gozalan A, Oncul O, Citil BE, Esen B. Co-trimox- azole and quinolone resistance in Escherichia coli isolated from uri- nary tract infections over the last 10 years. Int J Antimicrob Agents 2005; 26: 75-7. [CrossRef] 9. Kurutepe S, Surucuoglu S, Sezgin C, Gazi H, Gulay M, Ozbakkalo- glu B. Increasing antimicrobial resistance in Escherichia coli isolates from community-acquired urinary tract infections during 1998-2003 in Manisa, Turkey. Jpn J Infect Dis 2005; 58: 159-61. 10. Raz R, Chazan B, Kennes Y, Colodner R, Rottensterich E, Dan M, et al. Empiric use of trimethoprim-sulfamethoxazole (TMP-SMX) in the treatment of women with uncomplicated urinary tract infections in a geographical area with a high prevalence of TMP-SMX-resistant uropathogens. Clin Infect Dis 2002; 34: 1165-9. [CrossRef] 11. Falcone A, Amantea D, Levato A, et al. Outcomes of a pharmacoepide- miological survey on the antibiotic treatment of uncomplicated acute cystitis in community. Pharmacol Res 2006; 53: 193-6. [CrossRef] 12. Ar